Germany Cardiovascular Devices Market | Growth, Trends, and Forecasts

ABOUT THIS REPORT
- Market Snapshot
- Market Overview
- Scope of the report
- Key Market Trends
- Competitive Landscape
- Major Players
TABLE OF CONTENTS

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

CAGR:

5.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Germany Cardiovascular Devices Market is expected to register a CAGR of 5.6% during the forecast period. The major factors driving the growth of the market in Germany are technological advancements, increasing cases of cardiovascular diseases, and increased adoption of minimally invasive procedures.

As per Eurostat 2019 report, in 2017 , in Germany around 29% of surgical operations and procedures performed related to diseases of the circulatory system which was considerably higher than in any of the other EU Member States. More number of population are undergoing cardiopulmonary bypass procedures in this country due to cardiovascular diseases which ultimately increases the use of cardiovascular devices and shows positive impact on market.

Thus, owing to the above-mentioned factors the market is expected to show growth over the forecast period. However, stringent regulatory policies and the high cost of instruments and procedures are some of the major factors restraining market growth.

Scope of the report

As per the scope of the report, Cardiovascular diseases are a group of disorders of the heart and blood vessels that includes coronary heart disease, peripheral arterial disease, congenital heart disease, and cerebrovascular disease. The cardiovascular devices are used to treat or prevent different cardiovascular conditions. The Germany Cardiovascular Devices Market is segmented by device type.

By Device Type

Diagnostic and Monitoring Devices
	Electrocardiogram (ECG)
	Remote Cardiac Monitoring
	Other Diagnostic and Monitoring Devices

Therapeutic and Surgical Devices
	Cardiac Assist Devices
	Cardiac Rhythm Management Device
	Catheter
	Grafts
	Heart Valves
	Stents
	Other Therapeutic and Surgical Devices

Report scope can be customized per your requirements. Click here.

Key Market Trends

Electrocardiogram (ECG) is Expected to Dominate the Diagnostic And Monitoring Segment Over the Forecast Period

An electrocardiogram (ECG) records the electrical signals from the heart. It is a common and painless test used to detect heart problems and monitor the heart's health.

Currently, there are portable and compact electrocardiogram (ECG) is driving its greater adoption, especially in the home healthcare segment. Due to rising cases of cardiovascular diseases (CVD), wherein long-term ECG monitoring is necessary and with the introduction of wireless ECG, doctors can monitor and diagnose the patient remotely on time, which further fuels the market growth.

As per Eurostat 2019 report, in 2017 approximately 48,000 heart bypasses were conducted in Germany. Germany recorded the highest number of operations, and this was the fourth highest frequency when taking account of the population size (58.5 per 100000 inhabitants).

Therefore, the growing demand for minimally invasive surgeries and technological advancements is expected to drive the market in the near future.

To understand key trends, Download Sample Report

Competitive Landscape

The Germany Cardiovascular Devices market is consolidated competitive. The major players have established themselves in specific segments of the market. Some of the players who are currently dominating the market are Abbott Laboratories, Boston Scientific Corporation, Cardinal Health Inc, Edwards Lifesciences, GE Healthcare, W. L. Gore & Associates, Inc, Medtronic PLC, Biotronik, Siemens Healthineers AG, and Canon Medical Systems Corporation.

Major Players

You can also purchase parts of this report. Do you want to check out a section wise price list?

1. INTRODUCTION
1. 1.1 Study Assumptions
2. 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. 4.1 Market Overview
2. 4.2 Market Drivers
  1. 4.2.1 Increasing Burden of Cardiovascular Diseases
  2. 4.2.2 Increased Preference of Minimally Invasive Procedures
3. 4.3 Market Restraints
  1. 4.3.1 Stringent Regulatory Policies
4. 4.4 Porter's Five Force Analysis
  1. 4.4.1 Threat of New Entrants
  2. 4.4.2 Bargaining Power of Buyers/Consumers
  3. 4.4.3 Bargaining Power of Suppliers
  4. 4.4.4 Threat of Substitute Products
  5. 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
1. 5.1 By Device Type
  1. 5.1.1 Diagnostic and Monitoring Devices
    1. 5.1.1.1 Electrocardiogram (ECG)
    2. 5.1.1.2 Remote Cardiac Monitoring
    3. 5.1.1.3 Other Diagnostic and Monitoring Devices
  2. 5.1.2 Therapeutic and Surgical Devices
    1. 5.1.2.1 Cardiac Assist Devices
    2. 5.1.2.2 Cardiac Rhythm Management Device
    3. 5.1.2.3 Catheter
    4. 5.1.2.4 Grafts
    5. 5.1.2.5 Heart Valves
    6. 5.1.2.6 Stents
    7. 5.1.2.7 Other Therapeutic and Surgical Devices
6. COMPETITIVE LANDSCAPE
1. 6.1 Company Profiles
  1. 6.1.1 Abbott Laboratories
  2. 6.1.2 Boston Scientific Corporation
  3. 6.1.3 Cardinal Health Inc
  4. 6.1.4 Edwards Lifesciences
  5. 6.1.5 GE Healthcare
  6. 6.1.6 W. L. Gore & Associates, Inc
  7. 6.1.7 Medtronic PLC
  8. 6.1.8 Biotronik
  9. 6.1.9 Siemens Healthineers AG
  10. 6.1.10 Canon Medical Systems Corporation

*List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments